SK pharmteco was recently featured in “BioProcess International” in their article titled “Elevating the CGT Manufacturing Game: How Outsourcing Enables Success“. The cell and gene therapy (CGT) manufacturing industry is on the cusp of a major transformation. Discover how partnerships with contract development manufacturing organizations (CDMOs) with advanced technologies, strategic alliances, and AI integration are revolutionizing the field, while addressing challenges like talent shortages. Read the full article for expert insights from Audrey Greenberg, Co-Founder of the Center for Breakthrough Medicines and Chief Business Officer at SK pharmteco, Omkar Kawalekar, Senior Manager at Deloitte Consulting LLP., and Amit Agarwal, Managing Director of Life Sciences at Deloitte Consulting LLP.
Read the full article: https://www.bioprocessintl.com/cell-therapies/elevating-the-cgt-manufacturing-game-how-outsourcing-enables-success